Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials

Published:2019-01-09 Issue:1 Volume:19 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Meng Shan-Shan,Chang Wei,Lu Zhong-Hua,Xie Jian-Feng,Qiu Hai-Bo,Yang Yi,Guo Feng-Mei

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities; Postgraduate Research & Practice Innovation Program of Jiangsu Province

Jiangsu Province’s Medical Key Discipline

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12890-018-0761-y.pdf

Reference20 articles.

1. Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016;388:2416–30.

2. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800.

3. Gille C, Spring B, Bernhard W, Gebhard C, Basile D, Lauber K, et al. Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages. J Lipid Res. 2007;48:307–17.

4. Clark HW. Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease? Neonatology. 2010;97:380–7.

5. Halliday HL. Recent clinical trials of surfactant treatment for neonates. Biol Neonate. 2006;89:323–9.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the pharmacological management of acute respiratory distress syndrome;Expert Opinion on Pharmacotherapy;2024-06-12

2. Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs;European Journal of Pharmaceutical Sciences;2024-05

3. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits;Lung;2024-04-29

4. Use of surfactant beyond respiratory distress syndrome, what is the evidence?;Journal of Perinatology;2024-03-08

5. A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial);Scientific Reports;2023-11-28